These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 3873263)

  • 1. Growth factor-mediated proliferation in B cell non-Hodgkin's lymphomas.
    Ford RJ; Kouttab NM; Sahasrabuddhe CG; Davis FM; Mehta SR
    Blood; 1985 Jun; 65(6):1335-41. PubMed ID: 3873263
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Heterogeneity of B-cell growth factor receptor reactivity in healthy donors and in patients with chronic lymphatic leukemia: relationship to B-cell-derived lymphokines.
    Benjamin D; Bazar LS; Wallace B; Jacobson RJ
    Cell Immunol; 1986 Dec; 103(2):394-408. PubMed ID: 3100061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Growth factor-mediated tumor cell proliferation in hairy cell leukemia.
    Ford RJ; Yoshimura L; Morgan J; Quesada J; Montagna R; Maizel A
    J Exp Med; 1985 Sep; 162(3):1093-8. PubMed ID: 2993470
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Establishment of a human B cell line that proliferates in response to B cell growth factor.
    Abe H; Rossio JL; Ruscetti FW; Matsushima K; Oppenheim JJ
    J Immunol Methods; 1986 Jun; 90(1):111-23. PubMed ID: 2423613
    [TBL] [Abstract][Full Text] [Related]  

  • 5. B cell growth and differentiation factors interact with receptors distinct from the interleukin 2 receptor.
    Kehrl JH; Grove JH; Goldsmith PK; Fauci AS
    Eur J Immunol; 1986 Jul; 16(7):761-6. PubMed ID: 3013645
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergy of B cell growth factor and interleukin 2 in the proliferation of activated human B cells.
    Romagnani S; Giudizi GM; Maggi E; Almerigogna F; Biagiotti R; Del Prete G; Mazzetti M; Alessi A; Vercelli D; Ricci M
    Eur J Immunol; 1985 Dec; 15(12):1158-64. PubMed ID: 3936718
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Development and characterization of a human B cell line that responds to B cell growth factor but not interleukin 2.
    Tseng CT; Springgate CF; Piela TH; Choi YS
    J Immunol; 1987 Apr; 138(8):2554-60. PubMed ID: 3031160
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A B cell growth factor-dependent cell line derived from a human lymphocytic nodular lymphoma.
    Genot E; Kolb JP
    Scand J Immunol; 1987 Jul; 26(1):37-46. PubMed ID: 3112929
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heterogeneity of responsiveness of chronic lymphocytic leukemic B cells to B cell growth factor or interleukin 2.
    Hivroz C; Grillot-Courvalin C; Brouet JC; Seligmann M
    Eur J Immunol; 1986 Aug; 16(8):1001-4. PubMed ID: 3488907
    [TBL] [Abstract][Full Text] [Related]  

  • 10. B cell growth factor-induced proliferation of hairy cell lymphocytes and inhibition by type I interferon in vitro.
    Paganelli KA; Evans SS; Han T; Ozer H
    Blood; 1986 Apr; 67(4):937-42. PubMed ID: 2937473
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of human lymphoma cells by antisera to malignancy-associated nucleolar antigens.
    Ford RJ; Cramer M; Davis FM
    Blood; 1984 Mar; 63(3):559-65. PubMed ID: 6365200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Establishment and characterization of human B-cell lymphoma cell lines using B-cell growth factor.
    Ford RJ; Goodacre A; Ramirez I; Mehta SR; Cabanillas F
    Blood; 1990 Mar; 75(6):1311-8. PubMed ID: 2155676
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Stimulation of B-chronic lymphocytic leukemia populations by recombinant interleukin-4 and other defined growth-promoting agents.
    Ghaderi AA; Richardson P; Cardona C; Millsum MJ; Ling N; Gillis S; Ledbetter J; Gordon J
    Leukemia; 1988 Mar; 2(3):165-70. PubMed ID: 3126369
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a major 50-kDa molecular weight human B-cell growth factor with Tac antigen-inducing activity on B cells.
    Kawano M; Matsushima K; Oppenheim JJ
    Cell Immunol; 1987 Aug; 108(1):132-49. PubMed ID: 3111722
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phenotypic analysis by flow cytometry of surface immunoglobulin light chains and B and T cell antigens in lymph nodes involved with non-Hodgkin's lymphoma.
    Liendo C; Danieu L; Al-Katib A; Koziner B
    Am J Med; 1985 Oct; 79(4):445-54. PubMed ID: 3931469
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Different human B cell subsets respond to interleukin 2 and to a high molecular weight B cell growth factor (BCGF).
    Vazquez A; Gérard JP; Olive D; Auffredou MT; Dugas B; Karray S; Delfraissy JF; Galanaud P
    Eur J Immunol; 1986 Dec; 16(12):1503-7. PubMed ID: 3102243
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization and growth factor requirements of SJL lymphomas. I. Development of a B cell growth factor-dependent in vitro cell line, cRCS-X.
    Lasky JL; Ponzio NM; Thorbecke GJ
    J Immunol; 1988 Jan; 140(2):679-87. PubMed ID: 3275720
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activity of a partially purified human BCGF on murine assays for B cell stimulatory factors. II. Synergy between two distinct BCGF II-like factors in promoting B cell differentiation.
    Ennist DL; Elkins KL; Cheng SC; Howard M
    J Immunol; 1987 Sep; 139(5):1525-31. PubMed ID: 2957428
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Selective suppressive effects of glucocorticoids on the early events in the human B cell activation process.
    Bowen DL; Fauci AS
    J Immunol; 1984 Oct; 133(4):1885-90. PubMed ID: 6206141
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization and growth factor requirements of SJL lymphomas. II. Interleukin 5 dependence of the in vitro cell line, cRCS-X, and influence of other cytokines.
    Lasky JL; Thorbecke GJ
    Eur J Immunol; 1989 Feb; 19(2):365-71. PubMed ID: 2495224
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.